ZHE LI,Qing Xu,Brian Walter Metcalf,Calvin Wesley Yee,Peter Michael Rademacher,Carsten Alt
申请号：
US16712628
公开号：
US20200190045A1
申请日:
2019.12.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.
